Stocks and Investing Stocks and Investing
Thu, June 27, 2024

Doug Schenkel Downgraded (TXG) to Hold on, Jun 27th, 2024


Published on 2024-10-28 12:08:20 - WOPRAI, Doug Schenkel
  Print publication without navigation


Doug Schenkel of Wolfe Research, Downgraded "10x Genomics, Inc." (TXG) to Hold on, Jun 27th, 2024.

Doug has made no other calls on TXG in the last 4 months.



There are 10 other peers that have a rating on TXG. Out of the 10 peers that are also analyzing TXG, 5 agree with Doug's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Subbu Nambi of "Guggenheim" Downgraded from Strong Buy to Hold on, Wednesday, June 26th, 2024
  • Tycho Peterson of "Jefferies" Initiated at Hold and Held Target at $24 on, Monday, June 3rd, 2024
  • Dan Brennan of "TD Cowen" Downgraded from Strong Buy to Hold and Decreased Target to $32 on, Wednesday, May 1st, 2024
  • Dan Leonard of "UBS" Maintained at Hold with Decreased Target to $30 on, Wednesday, May 1st, 2024
  • Derik De Bruin of "B of A Securities" Maintained at Hold with Decreased Target to $36 on, Wednesday, May 1st, 2024


These are the ratings of the 5 analyists that currently disagree with Doug


  • Daniel Arias of "Stifel" Maintained at Strong Buy with Decreased Target to $53 on, Wednesday, May 1st, 2024
  • Matthew Sykes of "Goldman Sachs" Maintained at Strong Sell with Decreased Target to $26 on, Wednesday, May 1st, 2024
  • Kyle Mikson of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $50 on, Monday, April 29th, 2024
  • Justin Bowers of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $55 on, Thursday, April 18th, 2024
  • Luke Sergott of "Barclays" Maintained at Buy with Decreased Target to $45 on, Wednesday, April 10th, 2024
Contributing Sources